Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Autoimmune hemolytic anemia in children: Classification, clinical features, and diagnosis

Russell E Ware, MD, PhD
Section Editor
Donald H Mahoney, Jr, MD
Deputy Editor
Carrie Armsby, MD, MPH


Autoimmune hemolytic anemia (AIHA) is a collection of disorders characterized by the presence of autoantibodies that bind to the patient's own erythrocytes, leading to premature red cell destruction (ie, hemolysis) and, when the rate of hemolysis exceeds the ability of the bone marrow to replace the destroyed red cells, to anemia and its attendant signs and symptoms.

The classification, clinical presentation, and diagnosis of AIHA in children are reviewed here. A general overview of childhood hemolytic anemias is presented separately, as are other aspects related to AIHA, including pathophysiology, treatment, and prognosis of AIHA, and diagnosis and management of paroxysmal cold hemoglobinuria:

(See "Overview of hemolytic anemias in children".)

(See "Autoimmune hemolytic anemia in children: Treatment and outcome".)

(See "Pathogenesis of autoimmune hemolytic anemia: Warm agglutinins and drugs".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Sep 02, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Aladjidi N, Leverger G, Leblanc T, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011; 96:655.
  2. Vaglio S, Arista MC, Perrone MP, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion 2007; 47:50.
  3. Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol 1992; 29:3.
  4. Fong KY, Loizou S, Boey ML, Walport MJ. Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 1992; 31:453.
  5. Boling EP, Wen J, Reveille JD, et al. Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. Am J Med 1983; 74:1066.
  6. Chou ST, Schreiber AD. Autoimmune hemolytic anemia. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 8th ed, Orkin SH, Fisher DE, Look T, Lux SE, Ginsburg D, Nathan DG (Eds), WB Saunders, Philadelphia 2015. p.411.
  7. Blanchette VS, Hallett JJ, Hemphill JM, et al. Abnormalities of the peripheral blood as a presenting feature of immunodeficiency. Am J Hematol 1978; 4:87.
  8. Pui CH, Wilimas J, Wang W. Evans syndrome in childhood. J Pediatr 1980; 97:754.
  9. Norton A, Roberts I. Management of Evans syndrome. Br J Haematol 2006; 132:125.
  10. Wang W, Herrod H, Pui CH, et al. Immunoregulatory abnormalities in Evans syndrome. Am J Hematol 1983; 15:381.
  11. Pegels JG, Helmerhorst FM, van Leeuwen EF, et al. The Evans syndrome: characterization of the responsible autoantibodies. Br J Haematol 1982; 51:445.
  12. Teachey DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 2005; 105:2443.
  13. Seif AE, Manno CS, Sheen C, et al. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood 2010; 115:2142.
  14. Chu JY. Autoimmune hemolytic anemia in childhood Hodgkin's disease. Am J Pediatr Hematol Oncol 1982; 4:125.
  15. Sokol RJ, Hewitt S, Booker DJ. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes. J Clin Pathol 1989; 42:1088.
  16. O'Brien TA, Eastlund T, Peters C, et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004; 127:67.
  17. Murray HW, Masur H, Senterfit LB, Roberts RB. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med 1975; 58:229.
  18. Rosenfield RE, Schmidt PJ, Calvo RC, McGinniss MH. Anti-i, a frequent cold agglutinin in infectious mononucleosis. Vox Sang 1965; 10:631.
  19. Rollof J, Eklund PO. Infectious mononucleosis complicated by severe immune hemolysis. Eur J Haematol 1989; 43:81.
  20. Bell CA, Zwicker H, Rosenbaum DL. Paroxysmal cold hemoglobinuria (P.C.H.) following mycoplasma infection: anti-I specificity of the biphasic hemolysin. Transfusion 1973; 13:138.
  21. Boccardi V, D'Annibali S, Di Natale G, et al. Mycoplasma pneumoniae infection complicated by paroxysmal cold hemoglobinuria with anti-P specificity of biphasic hemolysin. Blut 1977; 34:211.
  22. König AL, Schabel A, Sugg U, et al. Autoimmune hemolytic anemia caused by IgG lambda-monotypic cold agglutinins of anti-Pr specificity after rubella infection. Transfusion 2001; 41:488.
  23. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis associated with Donath-Landsteiner antibodies. Acta Haematol 1982; 68:268.
  24. Göttsche B, Salama A, Mueller-Eckhardt C. Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang 1990; 58:281.
  25. Daikeler T, Labopin M, Ruggeri A, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood 2013; 121:1059.
  26. Faraci M, Zecca M, Pillon M, et al. Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. Biol Blood Marrow Transplant 2014; 20:272.
  27. Schoettler M, Elisofon SA, Kim HB, et al. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer 2015; 62:214.
  28. Hosoba S, Jaye DL, Cohen C, et al. Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature. Transfusion 2015; 55.
  29. Koepsell SA, Grant W, Landmark JD. Autoantibodies to red blood cell antigens occur frequently with hemolysis among pediatric small bowel transplant recipients: clinical implications and management. Pediatr Transplant 2015; 19:62.
  30. Valentini RP, Imam A, Warrier I, et al. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia. Pediatr Transplant 2006; 10:358.
  31. Petz LD. Drug-induced immune haemolytic anaemia. Clin Haematol 1980; 9:455.
  32. Garratty G, Arndt PA. Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology 2014; 30:66.
  33. Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987; 69:1006.
  34. Schreiber AD, Rosse WF, Frank MM. Autoimmune hemolytic anemia. In: Samter's Immunologic Diseases, 5th, Frank MM, Austen KF, Claman HN, Unanue ER (Eds), Little, Brown, and Company, Boston 1995. p.903.
  35. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002; 69:258.
  36. Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med 1974; 56:61.
  37. Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol 1984; 72:245.
  38. Zupańska B, Lawkowicz W, Górska B, et al. Autoimmune haemolytic anaemia in children. Br J Haematol 1976; 34:511.
  39. Wolach B, Heddle N, Barr RD, et al. Transient Donath-Landsteiner haemolytic anaemia. Br J Haematol 1981; 48:425.
  40. Heisel MA, Ortega JA. Factors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1983; 5:147.
  41. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003; 101:3857.
  42. Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am 2013; 60:1489.
  43. Naithani R, Agrawal N, Mahapatra M, et al. Autoimmune hemolytic anemia in children. Pediatr Hematol Oncol 2007; 24:309.
  44. Vagace JM, Bajo R, Gervasini G. Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children. Arch Dis Child 2014; 99:668.
  45. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987; 69:820.
  46. Reusser P, Osterwalder B, Burri H, Speck B. Autoimmune hemolytic anemia associated with IgA--diagnostic and therapeutic aspects in a case with long-term follow-up. Acta Haematol 1987; 77:53.
  47. Freedman J, Wright J, Lim FC, Garvey MB. Hemolytic warm IgM autoagglutinins in autoimmune hemolytic anemia. Transfusion 1987; 27:464.
  48. Javid J. Human serum haptoglobins: a brief review. Semin Hematol 1967; 4:35.
  49. Rosse WF. Fixation of the first component of complement (C'la) by human antibodies. J Clin Invest 1969; 47:2430.